A multidisciplinary team of experts from five research institutes will collaborate on the effort, which aims to develop variant-proof, universal vaccines that offer long-lasting protection against coronaviruses.
Researchers will study what supports a strong and long-lasting immune response against the viruses and use those findings to inform the development of vaccines for SARS-CoV-2 and other coronaviruses.
“Our multidisciplinary team is poised to tackle the challenges posed by coronaviruses head on,” Viviana Simon, MD, PhD, a professor at the Icahn School of Medicine who is leading the project, said in a Sept. 12 news release. “By pooling our expertise and resources, we aim to develop next-generation coronavirus vaccines with broad protection, thus contributing significantly to curbing the current pandemic and averting future coronavirus-related public health crises.”
Learn more about the effort here.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
